303 related articles for article (PubMed ID: 24196788)
41. Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer.
Ishigami S; Arigami T; Uenosono Y; Matsumoto M; Okumura H; Uchikado Y; Kita Y; Nishizono Y; Maemura K; Kijima Y; Nakajo A; Owaki T; Ueno S; Hokita S; Natsugoe S
Cancer Immunol Immunother; 2012 Oct; 61(10):1663-9. PubMed ID: 22374482
[TBL] [Abstract][Full Text] [Related]
42. Elevated expression of SerpinA1 and SerpinA3 in HLA-positive cervical carcinoma.
Kloth JN; Gorter A; Fleuren GJ; Oosting J; Uljee S; ter Haar N; Dreef EJ; Kenter GG; Jordanova ES
J Pathol; 2008 Jul; 215(3):222-30. PubMed ID: 18438953
[TBL] [Abstract][Full Text] [Related]
43. A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer: Alliance (Cancer and Leukemia Group B) 9581 and 89803.
Niedzwiecki D; Hasson RM; Lenz HJ; Ye C; Redston M; Ogino S; Fuchs CS; Compton CC; Mayer RJ; Goldberg RM; Colacchio TA; Saltz LB; Warren RS; Bertagnolli MM
Oncologist; 2017 Jan; 22(1):107-114. PubMed ID: 27821793
[TBL] [Abstract][Full Text] [Related]
44. HLA non-A,B,C class I genes: their structure and expression.
Heinrichs H; Orr HT
Immunol Res; 1990; 9(4):265-74. PubMed ID: 2089074
[TBL] [Abstract][Full Text] [Related]
45. HLA-G, -E, -F preworkshop: tools and protocols for analysis of non-classical class I genes transcription and protein expression.
Paul P; Rouas-Freiss N; Moreau P; Cabestre FA; Menier C; Khalil-Daher I; Pangault C; Onno M; Fauchet R; Martinez-Laso J; Morales P; Villena AA; Giacomini P; Natali PG; Frumento G; Ferrara GB; McMaster M; Fisher S; Schust D; Ferrone S; Dausset J; Geraghty D; Carosella ED
Hum Immunol; 2000 Nov; 61(11):1177-95. PubMed ID: 11137224
[TBL] [Abstract][Full Text] [Related]
46. Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors.
Tao J; Li Y; Liu YQ; Li L; Liu J; Shen X; Shen GX; Tu YT
Br J Dermatol; 2008 Jan; 158(1):88-94. PubMed ID: 17999701
[TBL] [Abstract][Full Text] [Related]
47. Distribution of HLA-G extended haplotypes and one HLA-E polymorphism in a large-scale study of mother-child dyads with and without severe preeclampsia and eclampsia.
Nilsson LL; Djurisic S; Andersen AM; Melbye M; Bjerre D; Ferrero-Miliani L; Hackmon R; Geraghty DE; Hviid TV
HLA; 2016 Oct; 88(4):172-86. PubMed ID: 27596021
[TBL] [Abstract][Full Text] [Related]
48. Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer.
Lefebvre S; Antoine M; Uzan S; McMaster M; Dausset J; Carosella ED; Paul P
J Pathol; 2002 Mar; 196(3):266-74. PubMed ID: 11857488
[TBL] [Abstract][Full Text] [Related]
49. The Impact of
Ouni N; Chaaben AB; Kablouti G; Ayari F; Douik H; Abaza H; Gara S; Elgaaied-Benammar A; Guemira F; Tamouza R
Immunol Invest; 2019 Jul; 48(5):521-532. PubMed ID: 30945586
[TBL] [Abstract][Full Text] [Related]
50. Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patients.
de Kruijf EM; Engels CC; van de Water W; Bastiaannet E; Smit VT; van de Velde CJ; Liefers GJ; Kuppen PJ
Breast Cancer Res Treat; 2013 Nov; 142(2):355-64. PubMed ID: 24197659
[TBL] [Abstract][Full Text] [Related]
51. Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.
Ruiz-Cabello F; Lopez Nevot MA; Gutierrez J; Oliva MR; Romero C; Ferron A; Esteban F; Huelin C; Piris MA; Rivas C
Clin Exp Metastasis; 1989; 7(2):213-26. PubMed ID: 2493352
[TBL] [Abstract][Full Text] [Related]
52. High expression of HLA-E in colorectal carcinoma is associated with a favorable prognosis.
Benevolo M; Mottolese M; Tremante E; Rollo F; Diodoro MG; Ercolani C; Sperduti I; Lo Monaco E; Cosimelli M; Giacomini P
J Transl Med; 2011 Oct; 9():184. PubMed ID: 22032294
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of host immune response in colorectal cancer: human leukocyte antigen-G and beyond.
Garziera M; Toffoli G
World J Gastroenterol; 2014 Apr; 20(14):3778-94. PubMed ID: 24744572
[TBL] [Abstract][Full Text] [Related]
54. High Expression of Human Leukocyte Antigen-G is Associated with a Poor Prognosis in Patients with PDAC.
Xu YF; Lu Y; Cheng H; Jiang J; Xu J; Long J; Liu L; Ni Q; Liu C; Yu XJ
Curr Mol Med; 2015; 15(4):360-7. PubMed ID: 25829020
[TBL] [Abstract][Full Text] [Related]
55. New Insights Into the Role of Qa-2 and HLA-G Non-classical MHC-I Complexes in Malignancy.
da Silva IL; Montero-Montero L; Ferreira E; Quintanilla M
Front Immunol; 2018; 9():2894. PubMed ID: 30574154
[TBL] [Abstract][Full Text] [Related]
56. [Research progress on HLA-G in non-small cell lung cancer].
Li R; Guo Z; Zhang X; Xiao L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Feb; 40(2):174-178. PubMed ID: 38284259
[TBL] [Abstract][Full Text] [Related]
57. Intraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinoma.
Sinicrope FA; Rego RL; Ansell SM; Knutson KL; Foster NR; Sargent DJ
Gastroenterology; 2009 Oct; 137(4):1270-9. PubMed ID: 19577568
[TBL] [Abstract][Full Text] [Related]
58. HLA-G and HLA-E specific mRNAs connote opposite prognostic significance in renal cell carcinoma.
Kren L; Valkovsky I; Dolezel J; Capak I; Pacik D; Poprach A; Lakomy R; Redova M; Fabian P; Krenova Z; Slaby O
Diagn Pathol; 2012 May; 7():58. PubMed ID: 22640987
[TBL] [Abstract][Full Text] [Related]
59. Expression of HLA class I antigens in sporadic adenomas and histologically normal mucosa of the colon.
Tsioulias GJ; Triadafilopoulos G; Goldin E; Papavassiliou ED; Rizos S; Bassioukas P; Rigas B
Cancer Res; 1993 May; 53(10 Suppl):2374-8. PubMed ID: 8485724
[TBL] [Abstract][Full Text] [Related]
60. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
Mehta AM; Jordanova ES; Kenter GG; Ferrone S; Fleuren GJ
Cancer Immunol Immunother; 2008 Feb; 57(2):197-206. PubMed ID: 17622526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
